Zetomipzomib maleateProduct ingredient for Zetomipzomib

Show full entry for Zetomipzomib
Name
Zetomipzomib maleate
Drug Entry
Zetomipzomib

Zetomipzomib is under investigation in clinical trial NCT04033926 (A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis).

See full entry for Zetomipzomib
Accession Number
DBSALT003392
Structure
Synonyms
(2S,3R)-N-[(2S)-3-(cyclopent-1-en-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]propanamido]propanamide maleate / KZR-616 maleate
UNII
N0CK0R203F
CAS Number
2170983-62-5
Not Available
Predicted Properties
Not Available